Log in to your Inderes Free account to see all free content on this page.
Nanoform Finland
1.52
EUR
+8.73 %
NANOFH
First North Finland
Medical Equipment & Services
Health Care
3,452 following
+8.73%
+35.71%
-1.55%
-12.64%
-23.69%
-4.1%
-11.63%
-78.74%
-
-69.9%
nanoform.com/en/section/investors
Nanoform Finland is a medical technology company. The company specializes in the research and development of technical products used to create nanoparticles in pharmaceuticals. The technology is used as a complement in the production process and is used for the treatment of diseases such as ALS and Alzheimer's. The customers consist of companies in the global pharmaceutical industry. Nanoform Finland mainly operates in the Nordic market and is headquartered in Helsinki.
Revenue
2.57M
EBIT %
-874.71 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Finland
NANOFH
Daily low / high price
1.41 / 1.566
EUR
Market cap
130.01M EUR
Turnover
138.98K EUR
Volume
92K
Latest videos
Financial calendar
Annual report
27.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Handelsbanken Funds | 7.1 % | 7.1 % |
Edward Hæggström | 6.3 % | 6.3 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Nanoform Finland Plc - Manager's Transactions - Albert Hæggström
Nanoform, Audiocast with teleconference, Q3'24
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio